A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP
NCT ID: NCT02456155
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
60 participants
INTERVENTIONAL
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary endpoint:
Success rate.
Secondary Endpoint:
Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after placement), Tolerance of enteral nutrition, Time to approach the target calories.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents
NCT01585662
Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections
NCT05281458
Nasogastric Decompression Following Pancreaticoduodenectomy
NCT06413888
Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy
NCT02594956
EUS Guided Drainage of Post Pancreatitis Pancreatic Fluid Collection
NCT06280248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary endpoint:
Success rate.
Secondary Endpoint:
Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after placement), Tolerance of enteral nutrition, Time to approach the target calories.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultrasound group
using B ultrasound as a instruction technique to place Nasal Jejunal Tube
placing nasal jejunal tube with ultrasound
bedside placing nasal jejunal tube with ultrasound confirmation versus placing endoscopically
endoscope group
Conventional methods for placing Nasal Jejunal Tube
placing nasal jejunal tube endoscopically
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
placing nasal jejunal tube with ultrasound
bedside placing nasal jejunal tube with ultrasound confirmation versus placing endoscopically
placing nasal jejunal tube endoscopically
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients in acute phase of pancreatitis (within 2 weeks from onset);
* the severity of pancreatitis is equal to or above moderate (according to the revised classification of pancreatitis).
Exclusion Criteria
* patients who have circulatory failure;
* patients who have gastrointestinal bleeding;
* patients who have specific diseases such as chronic digestive diseases and autoimmune diseases;
* patients in pregnancy.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Li Gang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Gang
Jinling Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
JinLing hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110-92
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.